Author(s)

Philip Davy, Brienne Walker, Livingston Wong, Richard Allsopp

.
Institute for Biogenesis Research, University of Hawai‘i at Mānoa, Honolulu, USA.

Recent studies suggest that whole bone marrow (WBM) derived stem cells may facilitate recovery following myocardial infarction. However, the sub-population of WBM responsible for recovery remains uncertain. By adjusting the abundance of CD34⁺Lin^Neg cells in human bone marrow we examined the relative significance of hematopoietic stem cells (HSC) in the recovery of cardiac function in a murine model of induced myocardial infarction. Enrichment of HSC by ~100-fold in WBM transplanted into mice significantly increased recovery of heart function and reduced scar size compared to transplantation of WBM depleted in HSC by ~10-fold (P < 0.05, and P < 0.01 respectively). Peri-infarct capillary density was significantly increased in recipients of HSC-enriched samples (P < 0.01) or WBM samples (P < 0.01) compared to controls. These results strongly suggest a critical role for HSC in the effective treatment of myocardial infarction with human bone marrow, and imply that enrichment of HSC may markedly benefit the clinical application of WBM treatments.

Hematopoietic Stem Cells; Myocardial Infarction; Transplantation; Cardiac Disease

Davy, P. , Walker, B. , Wong, L. and Allsopp, R. (2013) Hematopoietic stem cells are a critical sub-population of whole bone marrow in the treatment of myocardial infarction. Stem Cell Discovery, 3, 117-126. doi: 10.4236/scd.2013.32016.